B&K Corporation Limited (02396.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 3.90

From 52W high−85.19%

Volume33000.00

Market capHKD 332.09M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 3.90

From 52W high

−85.19%

Volume

33000.00

Market cap

HKD 332.09M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

43.9

MomentumView details →

1D Return

+9.59%

YTD Return

−75.26%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+9.59%

YTD Return

−75.26%

1Y Return

—

RSI (14)

43.9

vs 50D SMA

−4.92%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Qingcheng New Drug reported an interim loss of RMB 122 million for the six months ended June 2026, widening from RMB 86.68 million a year earlier, with no dividend declared.35d ago

Hua Ran Bio (02396.HK) announced that its stock short name will change to 'Qingcheng New Drug-B' from July 22, 2026.65d ago

Similar companies

EyePoint Pharmaceuticals, Inc.EYPT Century Therapeutics, Inc.IPSC Compass Therapeutics, Inc.CMPX Inhibikase Therapeutics, Inc.IKT Lexeo Therapeutics, Inc. Common StockLXEO SAB Biotherapeutics, Inc.SABS Find similar companies →

Latest newsMore news →

Qingcheng New Drug reported an interim loss of RMB 122 million for the six months ended June 2026, widening from RMB 86.68 million a year earlier, with no dividend declared.35d ago Hua Ran Bio (02396.HK) announced that its stock short name will change to 'Qingcheng New Drug-B' from July 22, 2026.65d ago